Down-regulation of osteopontin attenuates breast tumour progression in vivo

Development of breast tumour malignancies results in enhanced expression of various oncogenic molecules. Elevated expression of osteopontin (OPN) in higher grades of breast carcinoma correlates with enhanced expressions of several oncogenic molecules (urokinase-type plasminogen activator [uPA], matr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Goutam, Jain, Shalini, Patil, Tushar V, Kundu, Gopal C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514110/
https://www.ncbi.nlm.nih.gov/pubmed/18266970
http://dx.doi.org/10.1111/j.1582-4934.2008.00263.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514110/
https://www.ncbi.nlm.nih.gov/pubmed/18266970
http://dx.doi.org/10.1111/j.1582-4934.2008.00263.x

Ejemplares similares